Related Experiment Video
Updated: Sep 17, 2025
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Association of Cardiac Biomarkers With Structural Brain Changes and Cognitive Impairment: Results From the Hamburg
Märit Jensen1,2, Eik Vettorazzi3, Philipp Weber3
1Department of Neurology, University Medical Center Hamburg-Eppendorf, Germany.
Insights
Cardiac biomarkers like NT-proBNP are linked to brain changes and cognitive impairment. Monitoring these markers may help assess dementia risk and guide early prevention strategies.
Area of Science:
- Cardiology
- Neurology
- Neuroimaging
Background:
- Cardiovascular disease is a known risk factor for dementia.
- Investigating the link between cardiac health and brain structure is crucial for understanding dementia pathogenesis.
Purpose of the Study:
- To determine if blood-based cardiac biomarkers correlate with structural brain changes and cognitive decline.
- To explore if brain structural changes mediate the relationship between cardiac biomarkers and cognitive function.
Main Methods:
- Utilized data from the population-based Hamburg City Health Study (N=2,553).
- Measured high-sensitivity cardiac troponin I (hs-cTnI), midregional pro-atrial natriuretic peptide, and N-terminal pro-B-type natriuretic peptide (NT-proBNP).
- Assessed brain structure via MRI (neurodegeneration, vascular damage, network organization) and cognitive function (CERAD-Plus battery).
- Employed multivariable regression and structural equation modeling.
Main Results:
- Higher natriuretic peptide levels correlated with neurodegeneration and vascular brain damage markers.
- Elevated NT-proBNP was associated with reduced cortical thickness and increased white matter hyperintensity.
- Cardiac biomarkers indicated altered structural brain connectivity.
- NT-proBNP levels were linked to poorer verbal memory and fluency, with mediation by structural brain changes.
Conclusions:
- Cardiac biomarkers, particularly NT-proBNP, may serve as accessible indicators for cognitive risk.
- These biomarkers could potentially guide early interventions for cognitive decline.
- Further longitudinal studies are required to confirm causality.
Background And Objectives:
Cardiovascular disease is linked to an increased risk of dementia. The aim of this study was to evaluate whether blood-based cardiac biomarkers are associated with structural brain changes and cognitive impairment and to explore whether structural brain changes mediate alterations in cognitive function.
Methods:
We included participants from the population-based Hamburg City Health Study, recruiting citizens between 45 and 74 years of age. High-sensitivity cardiac troponin I (hs-cTnI), midregional pro-atrial natriuretic peptide, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations were measured. From brain MRI, we quantified markers of neurodegeneration (total brain volume, cortical thickness), markers of vascular brain damage (white matter hyperintensity volume, peak width of skeletonized mean diffusivity [PSMD]), and measures of structural brain network organization. Cognitive function was assessed using subtests of the CERAD-Plus battery. We applied multivariable-adjusted linear regression analyses and structural equation modeling to investigate the association of cardiac biomarkers with structural brain changes and cognitive function.
Results:
The analysis included 2,553 participants with a median age of 64 years, and 44% were women. Higher levels of natriuretic peptides were associated with imaging markers of neurodegeneration and vascular brain damage, for example, higher levels of NT-proBNP with lower cortical thickness (β = -0.081; 95% CI [-0.127 to -0.034]) and higher PSMD (β = 0.112; 95% CI [0.069-0.155]). Higher levels of hs-cTnI were associated with markers of vascular brain damage only, for example, with higher PSMD (β = 0.103; 95% CI [0.060-0.146]). All cardiac biomarkers studied were associated with alterations of structural brain connectivity reflecting changes in brain network organization toward less integration and more segregation. Elevated NT-proBNP was associated with lower scores in tests of verbal memory (β = -0.054; 95% CI [-0.100 to -0.008]) and verbal fluency (β = -0.054; 95% CI [-0.101 to -0.008]). In structural equation modeling, there was a significant effect of NT-proBNP on cognitive function mediated by structural brain changes.
Discussion:
Monitoring cardiac biomarkers, especially NT-proBNP, may provide a low-invasive and widely available method to assess cognitive risk and potentially guide early preventive interventions. Longitudinal studies are needed to establish causality and explore the observed associations over time.
Clinical Trial Registration:
ClinicalTrials.gov number, NCT03934957.
More Related Videos
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:14Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...